Coates R J, Click L A, Harlan L C, Robboy S, Barrett R J, Eley J W, Reynolds P, Chen V W, Darity W A, Blacklow R S, Edwards B K
Department of Epidemiology, Rollins School of Public Health of Emory University, Atlanta, GA 30322, USA.
Cancer Causes Control. 1996 May;7(3):328-36. doi: 10.1007/BF00052938.
To determine whether Black women with symptoms of uterine corpus cancer had longer times from symptom recognition to initial medical consultation than did White women in the United States, 331 newly diagnosed patients living in Atlanta (GA), New Orleans (LA), and San Francisco/Oakland (CA) during 1985-87 were interviewed to collect information on symptoms, dates of recognition and consultation, and other factors that might affect the interval. Data were analyzed to estimate medical consultation rates and rate ratios following symptom recognition. Median recalled times between symptom recognition and consultation were 16 days for Black women and 14 days for White women. Although poverty, having no usual source of healthcare, and other factors were associated with lower consultation rates, the adjusted rate among Black women was only somewhat lower (0.87) than among White women, and the 95 percent confidence interval (CI = 0.58-1.31) was consistent with no true difference between the races. In addition, the median time to consultation for women with stage IV cancer was only 15 days longer than the time (14 days) for the women with stage I cancer. These results suggest that time from symptom recognition to initial medical consultation does not contribute importantly to the more advanced stage cancer of the uterine corpus commonly found among Black women.
为确定在美国,有子宫体癌症状的黑人女性从症状识别到首次就医咨询的时间是否比白人女性更长,1985年至1987年期间,对居住在佐治亚州亚特兰大、路易斯安那州新奥尔良以及加利福尼亚州旧金山/奥克兰的331名新诊断患者进行了访谈,以收集有关症状、识别和咨询日期以及可能影响间隔时间的其他因素的信息。对数据进行分析,以估计症状识别后的就医咨询率和率比。黑人女性从症状识别到咨询的回忆中位时间为16天,白人女性为14天。尽管贫困、没有固定的医疗保健来源以及其他因素与较低的咨询率相关,但黑人女性的调整后比率仅略低于白人女性(0.87),且95%置信区间(CI = 0.58 - 1.31)表明种族之间无真正差异。此外,IV期癌症女性的咨询中位时间仅比I期癌症女性的时间(14天)长15天。这些结果表明,从症状识别到首次就医咨询的时间对黑人女性中常见的子宫体晚期癌症影响不大。